医学
非典型溶血尿毒综合征
血栓性微血管病
中止
异常
伊库利珠单抗
胃肠病学
危险系数
补体系统
累积发病率
置信区间
内科学
免疫学
疾病
队列
抗体
精神科
作者
Gianluigi Ardissino,Donata Cresseri,Maria Cristina Mancuso,Valentina Capone,Luigi Porcaro,Valeria Amico,Marianna Tangredi,Elena Grovetti,Samantha Griffini,Giuseppe Castellano,Giovanni Montini,Dario Consonni,Massimo Cugno,on behalf of the HUS-ItalKid Network.,Barbara Acaia,Aiuti Alessandro,Alfieri Carlo,A Kaufmann Karen,Atzeni Alice,Bruno Basolo
标识
DOI:10.1007/s40620-023-01873-9
摘要
Our data show a better outcome in aHUS patients treated with C5-inhibition, particularly in the primary and combined forms, which have a high risk of relapse after discontinuation that is not observed in the secondary and idiopathic forms.
科研通智能强力驱动
Strongly Powered by AbleSci AI